局灶性房性心动过速

1. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016 Apr 5;67(13):e27-e115.全文  摘要

2. Salerno JC, Kertesz NJ, Friedman RA, et al. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children <3 or >3 or = 3 years of age. J Am Coll Cardiol. 2004 Feb 4;43(3):438-44. 摘要

3. Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am. 2006 Feb;53(1):85-105, vi. 摘要

4. Ferguson JD, DiMarco JP. Contemporary management of paroxysmal supraventricular tachycardia. Circulation. 2003 Mar 4;107(8):1096-9. 摘要

5. Poutiainen AM, Koistinen MJ, Airaksinen KE, et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J. 1999 May;20(9):694-700. 摘要

6. Loomba RS, Chandrasekar S, Sanan P, et al. Association of atrial tachyarrhythmias with atrial septal defect, Ebstein's anomaly and Fontan patients. Expert Rev Cardiovasc Ther. 2011 Jul;9(7):887-93. 摘要

7. DeVoe JE, Judkins DZ, Woods L. What is the best approach to the evaluation of resting tachycardia in an adult? J Fam Pract. 2007 Jan;56(1):59-61. 摘要

8. Thavendiranathan P, Bagai A, Khoo C, et al. Does this patient with palpitations have a cardiac arrhythmia? JAMA. 2009 Nov 18;302(19):2135-43. 摘要

9. Hanrahan JP, Grogan DR, Baumgartner RA, et al. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine (Baltimore). 2008 Nov;87(6):319-28. 摘要

10. Gerstenfeld EP, Marchlinski FE. Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation. Heart Rhythm. 2007 Mar;4(suppl 3):S65-72. 摘要

11. Chauhan VS, Krahn GJ, Skanes AC, et al. Supraventricular tachycardia. Med Clin North Am. 2001 Mar;85(2):193-223, ix. 摘要

12. Fox DJ, Tischenko A, Krahn AD, et al. Supraventricular tachycardia: diagnosis and management. Mayo Clin Proc. 2008 Dec;83(12):1400-11. 摘要

13. Innes JA. Review article: adenosine use in the emergency department. Emerg Med Australas. 2008 Jun;20(3):209-15. 摘要

14. Engelstein ED, Lippman N, Stein KM, et al. Mechanism-specific effects of adenosine on atrial tachycardia. Circulation. 1994 Jun;89(6):2645-54. 摘要

15. Vecht JA, Saso S, Rao C, et al. Atrial septal defect closure is associated with a reduced prevalence of atrial tachyarrhythmia in the short to medium term: a systematic review and meta-analysis. Heart. 2010 Nov;96(22):1789-97. 摘要

16. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.全文  摘要

17. Pichon-Riviere A, Augustovski F, Garcia Marti S, et al. Cryoablation in cardiac arrhythmias in pediatric patients. Ciudad de Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS); 2008.

18. Antman EM, Wenger TL, Butler VP Jr, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation. 1990;81:1744-1752. 摘要

19. Perry J, Fenrich AL, Hulse JE, et al. Pediatric use of amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996 Apr;27(5):1246-50. 摘要

20. Nerheim P, Birger-Botkin S, Piracha L, et al. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004 Jul 20;110(3):247-52. 摘要